1,747
Views
2
CrossRef citations to date
0
Altmetric
Articles

Physiological testosterone replacement effects on male aged rats with orchiectomy-induced osteoporosis in advanced stage: a tomographic and biomechanical pilot study

, , , &
Pages 139-147 | Received 07 Apr 2021, Accepted 02 Oct 2021, Published online: 14 Oct 2021

References

  • Misiorowski W. Osteoporosis in men. Prz Menopauzalny. 2017;16(2):70–73.
  • Johnston CB, Dagar M. Osteoporosis in older adults. Med Clin North Am. 2020;104(5):873–884.
  • Stein E, Shane E. Secondary osteoporosis. Endocrinol Metab Clin North Am. 2003;32(1):115–134.
  • Harper KD, Weber TJ. Secondary osteoporosis. Diagnostic considerations. Endocrinol Metab Clin North Am. 1998;27(2):325–348.
  • Gennari L, Bilezikian JP. Osteoporosis in men. Endocrinol Metab Clin North Am. 2007;36(2):399–419.
  • Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208–219.
  • Mohamad NV, Soelaiman IN, Chin KY. A concise review of testosterone and bone health. Clin Interv Aging. 2016;11:1317–1324.
  • Golds G, Houdek D, Arnason T. Male hypogonadism and osteoporosis: the effects, clinical consequences, and treatment of testosterone deficiency in bone health. Int J Endocrinol. 2017;2017:4602129.
  • Mendoza FA, Le Roux M, Ahmed I. Primary osteoporosis in men: an unmet medical need. Fertil Steril. 2019;112(5):791–798.
  • Vanderschueren D, Vandenput L, Boonen S, et al. Androgens and bone. Endocr Rev. 2004;25(3):389–425.
  • Clarke BL, Khosla S. Androgens and bone. Steroids. 2009;74(3):296–305.
  • Rochira V. Late-onset hypogonadism: Bone health. Andrologia. 2020;8(6):1539–1550.
  • Tracz MJ, Sideras K, Bolona ER, et al. Testosterone use in men and its effects on bone health: a systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab. 2006;91(6):2011–2016.
  • Chin KY, Ima-Nirwana S. The effects of orchidectomy and supraphysiological testosterone administration on trabecular bone structure and gene expression in rats. Aging Male. 2015;18(1):60–66.
  • Lee MJ, Ryu HK, An SY, et al. Testosterone replacement and bone mineral density in male pituitary tumor patients. Endocrinol Metab. 2014;29(1):48–53.
  • Ryu SJ, Ryu DS, Kim JY, et al. Bone mineral density changes after orchiectomy using a scrotal approach in Rats. Korean J Spine. 2015;12(2):55–59.
  • Ryu SJ, Ryu DS, Kim JY, et al. Changes in bone metabolism in young castrated male rats. Yonsei Med J. 2016;57(6):1386–1394.
  • Martin-Fernandez M, Garzon-Marquez FM, Diaz-Curiel M, et al. Comparative study of the effects of osteoprotegerin and testosterone on bone quality in male orchidectomised rats. Aging Male. 2018;2018:1–13.
  • Yeh PS, Lee YW, Chang WH, et al. Biomechanical and tomographic differences in the microarchitecture and strength of trabecular and cortical bone in the early stage of male osteoporosis. PLoS One. 2019;14(8):e0219718.
  • de Paiva Goncalves V, Ortega AAC, Steffens JP, et al. Long-term testosterone depletion attenuates inflammatory bone resorption in the ligature-induced periodontal disease model. J Periodontol. 2018;89(4):466–475.
  • Callies F, Kollenkirchen U, von Zur MC, et al. Testosterone undecanoate: a useful tool for testosterone administration in rats. Exp Clin Endocrinol Diabetes. 2003;111(4):203–208.
  • Steffens JP, Coimbra LS, Rossa C, Jr, et al. Androgen receptors and experimental bone loss – an in vivo and in vitro study. Bone. 2015;81:683–690.
  • Rosales Rocabado JM, Kaku M, Nozaki K, et al. A multi-factorial analysis of bone morphology and fracture strength of rat femur in response to ovariectomy. J Orthop Surg Res. 2018;13(1):318.
  • Tajul Ariff AS, Soelaiman IN, Pramanik J, et al. Effects of eurycoma longifolia on testosterone level and bone structure in an aged orchidectomised rat model. Evid Based Complement Alternat Med. 2012;2012:818072.
  • Prakasam G, Yeh JK, Chen MM, et al. Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats. Bone. 1999;24(5):491–497.
  • Shuid AN, El-Arabi E, Effendy NM, et al. Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. BMC Complement Altern Med. 2012;12(1):152.
  • Ramli R, Khamis MF, Shuid AN. Bone Micro-CT assessments in an orchidectomised rat model supplemented with eurycoma longifolia. Evid Based Complement Alternat Med. 2012;2012:501858.
  • Keller TS, Mao Z, Spengler DM. Young’s modulus, bending strength, and tissue physical properties of human compact bone. J Orthop Res. 1990;8(4):592–603.
  • Vandenput L, Boonen S, Van Herck E, et al. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone. J Bone Miner Res. 2002;17(11):2080–2086.
  • Jamsa T, Jalovaara P, Peng Z, et al. Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone. 1998;23(2):155–161.
  • Vanderschueren D, Van Herck E, Suiker AM, et al. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology. 1992;130(5):2906–2916.
  • Zhang G, Wang S, Xu S, et al. The effect of formalin preservation time and temperature on the material properties of bovine femoral cortical bone Tissue. Ann Biomed Eng. 2019;47(4):937–952.
  • Fiedler IAK, Casanova M, Keplinger T, et al. Effect of short-term formaldehyde fixation on raman spectral parameters of bone quality. J Biomed Opt. 2018;23(11):1–6.
  • Schmidt C, Priemel M, Kohler T, et al. Precision and accuracy of peripheral quantitative computed tomography (pQCT) in the mouse skeleton compared with histology and microcomputed tomography (microCT). J Bone Miner Res. 2003;18(8):1486–1496.
  • Kanis JA, Johnell O, De Laet C, et al. A Meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375–382.
  • Borst SE, Conover CF, Carter CS, et al. Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase. Am J Physiol Endocrinol Metab. 2007;293(2):E507–14.
  • Borst SE, Lee JH, Conover CF. Inhibition of 5α-reductase blocks prostate effects of testosterone without blocking anabolic effects. Am J Physiol Endocrinol Metab. 2005;288(1):E222–7.